MyChesCo on MSN57m
Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific ConferencesCabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its investigational CD19-CAR T cell therapy, resecabtagene autoleucel (rese-cel), during two prominent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback